Naya Health secures funding for precision neuromodulation clinic

Precision neuromodulation specialist Naya Health Limited has raised an estimated £70k in a funding round that values the business at £2.2m. The London-based company utilizes non-invasive brain stimulation, specifically repetitive transcranial magnetic stimulation (rTMS), to treat conditions such as chronic pain, anxiety, depression, fatigue, and migraines. These clinical interventions target the neural root causes of symptoms to restore and optimize brain activity for patients seeking drug-free medical approaches.

Incorporated in June 2025, the firm operates its flagship clinic from the Until wellness space. The service model integrates evidence-based technology with trauma-informed therapy and holistic recovery pathways. Beyond mental health and pain management, the business addresses symptoms associated with peri/menopause, fibromyalgia, and ADHD.

The company reached its current headcount of 11 employees following an initial funding year in 2025 that saw £265k raised. Total funding recorded for 2026 prior to this round stands at £50k. This most recent allotment of shares occurred in July, with the corresponding paperwork filed in September.